NanoString Technologies, Inc. (NASDAQ:NSTG) Shares Acquired by HRT Financial LP

Posted by Defense World Staff on Jun 3rd, 2023

HRT Financial LP lifted its stake in shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Get Rating) by 177.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 87,710 shares of the biotechnology company’s stock after buying an additional 56,122 shares during the quarter. HRT Financial LP owned 0.19% of NanoString Technologies worth $699,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Point72 Hong Kong Ltd purchased a new stake in shares of NanoString Technologies during the 2nd quarter valued at about $57,000. Tower Research Capital LLC TRC raised its holdings in shares of NanoString Technologies by 181.5% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,705 shares of the biotechnology company’s stock valued at $73,000 after buying an additional 3,678 shares during the period. Fox Run Management L.L.C. purchased a new stake in shares of NanoString Technologies during the 4th quarter valued at about $100,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of NanoString Technologies by 39.3% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,214 shares of the biotechnology company’s stock valued at $105,000 after buying an additional 3,725 shares during the period. Finally, Principal Financial Group Inc. raised its holdings in shares of NanoString Technologies by 15.5% during the 4th quarter. Principal Financial Group Inc. now owns 13,675 shares of the biotechnology company’s stock valued at $109,000 after buying an additional 1,831 shares during the period.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on NSTG shares. Morgan Stanley dropped their price objective on NanoString Technologies from $17.00 to $16.00 and set an “equal weight” rating on the stock in a report on Thursday, March 2nd. StockNews.com upgraded NanoString Technologies from a “sell” rating to a “hold” rating in a report on Friday. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $17.83.

NanoString Technologies Stock Up 1.0 %

Shares of NASDAQ NSTG opened at $5.79 on Friday. NanoString Technologies, Inc. has a twelve month low of $4.37 and a twelve month high of $18.51. The company has a current ratio of 4.34, a quick ratio of 3.54 and a debt-to-equity ratio of 16.67. The business has a 50 day simple moving average of $8.52 and a 200-day simple moving average of $8.79.

NanoString Technologies (NASDAQ:NSTG – Get Rating) last issued its quarterly earnings results on Tuesday, February 28th. The biotechnology company reported ($0.95) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.34). NanoString Technologies had a negative net margin of 122.19% and a negative return on equity of 252.96%. The firm had revenue of $34.42 million during the quarter, compared to the consensus estimate of $33.15 million. Analysts expect that NanoString Technologies, Inc. will post -2.31 EPS for the current year.

Insider Activity at NanoString Technologies

In related news, Director Charles P. Waite, Jr. acquired 12,000 shares of NanoString Technologies stock in a transaction that occurred on Monday, March 13th. The stock was acquired at an average price of $8.35 per share, for a total transaction of $100,200.00. Following the transaction, the director now directly owns 23,300 shares of the company’s stock, valued at approximately $194,555. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CFO K Thomas Bailey acquired 15,000 shares of the company’s stock in a transaction dated Friday, May 26th. The shares were bought at an average price of $5.76 per share, with a total value of $86,400.00. Following the purchase, the chief financial officer now owns 75,388 shares of the company’s stock, valued at $434,234.88. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Charles P. Waite, Jr. bought 12,000 shares of the business’s stock in a transaction dated Monday, March 13th. The shares were bought at an average cost of $8.35 per share, for a total transaction of $100,200.00. Following the completion of the transaction, the director now directly owns 23,300 shares of the company’s stock, valued at $194,555. The disclosure for this purchase can be found here. Insiders purchased 104,900 shares of company stock worth $685,026 in the last 90 days. 2.50% of the stock is currently owned by company insiders.

NanoString Technologies Company Profile

(Get Rating)

NanoString Technologies, Inc engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular.